Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PBMT + Hyaluronic Acid for Interdental Papillary Loss
NCT07012525Phase 2Not yet recruiting
- Sponsor
- Dar Al Uloom University
- Start
- Sep 2025
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial (2 arms), sponsored by Dar Al Uloom University. Primary endpoint: Change in Papillary Deficient Area at 12 months. Planned start Sep 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07012525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07012525.